Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 383

1.

Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.

Rudnick DA, Liao Y, An JK, Muglia LJ, Perlmutter DH, Teckman JH.

Hepatology. 2004 Apr;39(4):1048-55.

PMID:
15057909
2.

Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.

Rudnick DA, Shikapwashya O, Blomenkamp K, Teckman JH.

Hepatology. 2006 Oct;44(4):976-82.

PMID:
17006946
3.

Fasting in alpha1-antitrypsin deficient liver: constitutive [correction of consultative] activation of autophagy.

Teckman JH, An JK, Loethen S, Perlmutter DH.

Am J Physiol Gastrointest Liver Physiol. 2002 Nov;283(5):G1156-65. Erratum in: Am J Physiol Gastrointest Liver Physiol 2003 Jan;284(1):following table of contents.

4.

Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.

Mencin A, Seki E, Osawa Y, Kodama Y, De Minicis S, Knowles M, Brenner DA.

Hepatology. 2007 Nov;46(5):1443-52.

PMID:
17668872
5.

Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency.

Teckman JH, An JK, Blomenkamp K, Schmidt B, Perlmutter D.

Am J Physiol Gastrointest Liver Physiol. 2004 May;286(5):G851-62. Epub 2003 Dec 18.

6.
7.

Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.

Geller SA, Nichols WS, Kim S, Tolmachoff T, Lee S, Dycaico MJ, Felts K, Sorge JA.

Hepatology. 1994 Feb;19(2):389-97.

PMID:
8294096
8.

Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.

Brunt EM, Blomenkamp K, Ahmed M, Ali F, Marcus N, Teckman J.

J Pediatr Gastroenterol Nutr. 2010 Nov;51(5):626-30. doi: 10.1097/MPG.0b013e3181e7ff55.

9.

Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease.

Rudnick DA, Perlmutter DH.

Hepatology. 2005 Sep;42(3):514-21. Review.

PMID:
16044402
10.

Liver carcinoma in PiZ alpha-1-antitrypsin deficiency.

Zhou H, Fischer HP.

Am J Surg Pathol. 1998 Jun;22(6):742-8.

PMID:
9630182
11.

Z and Mmalton-1-antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study.

Francalanci P, Santorelli FM, Saccani S, Bonetti MF, Medicina D, Coni P, Faa G, Callea F.

Liver Int. 2009 Nov;29(10):1593-6. doi: 10.1111/j.1478-3231.2009.02091.x. Epub 2009 Sep 10.

PMID:
19744266
13.

Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector.

Conlon TJ, Cossette T, Erger K, Choi YK, Clarke T, Scott-Jorgensen M, Song S, Campbell-Thompson M, Crawford J, Flotte TR.

Mol Ther. 2005 Nov;12(5):867-75. Epub 2005 Aug 8.

14.

Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response.

Teckman JH, Perlmutter DH.

Am J Physiol Gastrointest Liver Physiol. 2000 Nov;279(5):G961-74.

15.
16.

Oxidative stress contributes to liver damage in a murine model of alpha-1-antitrypsin deficiency.

Marcus NY, Blomenkamp K, Ahmad M, Teckman JH.

Exp Biol Med (Maywood). 2012 Oct;237(10):1163-72. doi: 10.1258/ebm.2012.012106. Epub 2012 Oct 26.

17.

Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype).

Lieberman J, Silton RM, Agliozzo CM, McMahon J.

Am J Clin Pathol. 1975 Sep;64(3):304-10.

PMID:
169686
18.
19.
20.

Gene therapy for human alpha1-antitrypsin deficiency in an animal model using SV40-derived vectors.

Duan YY, Wu J, Zhu JL, Liu SL, Ozaki I, Strayer DS, Zern MA.

Gastroenterology. 2004 Oct;127(4):1222-32. Erratum in: Gastroenterology. 2005 Mar;128(3):808.

PMID:
15480999

Supplemental Content

Support Center